Literature DB >> 28316528

Pulmonary Eosinophilia Following Infliximab Treatment for Crohn's Disease.

David T Rubin1, Sunana Sohi1, Rebecca A Shilling2, Steven R White2.   

Abstract

Entities:  

Year:  2006        PMID: 28316528      PMCID: PMC5350253     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


× No keyword cloud information.
  15 in total

1.  Crohn's disease involving the lung: resolution with infliximab.

Authors:  A I Alrashid; R D Brown; M L Mihalov; M Sekosan; B J Pastika; R P Venu
Journal:  Dig Dis Sci       Date:  2001-08       Impact factor: 3.199

2.  Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.

Authors:  J Keane; S Gershon; R P Wise; E Mirabile-Levens; J Kasznica; W D Schwieterman; J N Siegel; M M Braun
Journal:  N Engl J Med       Date:  2001-10-11       Impact factor: 91.245

3.  Pulmonary eosinophilia associated with montelukast.

Authors:  J Franco; M J Artés
Journal:  Thorax       Date:  1999-06       Impact factor: 9.139

Review 4.  Churg-Strauss syndrome in two patients receiving montelukast.

Authors:  P Guilpain; J-F Viallard; P Lagarde; P Cohen; M Kambouchner; J-L Pellegrin; L Guillevin
Journal:  Rheumatology (Oxford)       Date:  2002-05       Impact factor: 7.580

5.  Delayed hypersensitivity reaction and acute respiratory distress syndrome following infliximab infusion.

Authors:  Douglas L Riegert-Johnson; John A Godfrey; Jeffrey L Myers; Rolf D Hubmayr; William J Sandborn; Edward V Loftus
Journal:  Inflamm Bowel Dis       Date:  2002-05       Impact factor: 5.325

6.  Idiopathic chronic eosinophilic pneumonia. A clinical and follow-up study of 62 cases. The Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P).

Authors:  E Marchand; M Reynaud-Gaubert; D Lauque; J Durieu; A B Tonnel; J F Cordier
Journal:  Medicine (Baltimore)       Date:  1998-09       Impact factor: 1.889

Review 7.  Chronic eosinophilic pneumonia. A report of 19 cases and a review of the literature.

Authors:  P J Jederlinic; L Sicilian; E A Gaensler
Journal:  Medicine (Baltimore)       Date:  1988-05       Impact factor: 1.889

8.  Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma.

Authors:  M E Wechsler; D Finn; D Gunawardena; R Westlake; A Barker; S P Haranath; R A Pauwels; J C Kips; J M Drazen
Journal:  Chest       Date:  2000-03       Impact factor: 9.410

Review 9.  The lung in inflammatory bowel disease.

Authors:  P Camus; F Piard; T Ashcroft; A A Gal; T V Colby
Journal:  Medicine (Baltimore)       Date:  1993-05       Impact factor: 1.889

10.  Diffuse alveolar hemorrhage after infliximab treatment of Crohn's disease.

Authors:  Sofia Panagi; Wojciech Palka; Burton I Korelitz; Metin Taskin; Klaus D Lessnau
Journal:  Inflamm Bowel Dis       Date:  2004-05       Impact factor: 5.325

View more
  1 in total

1.  Lessons of the month 2: Chronic eosinophilic pneumonia (CEP): A rare manifestation of infliximab therapy.

Authors:  Iftikhar Nadeem; Usman Khatana; Masood Ur Rasool; Asma Wasil; Mohammed Azher
Journal:  Clin Med (Lond)       Date:  2020-07       Impact factor: 2.659

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.